Evidence map›Paper›PMID 34963446›Full record

ArticleMicrobial cell factories2021

Heterologous production of active form of beta-lytic protease by Bacillus subtilis and improvement of staphylolytic activity by protein engineering.

Takahiro Hioki, Daichi Yamashita, Masatoshi Tohata, Keiji Endo, Akihito Kawahara, Mitsuyoshi Okuda

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. The First Homologous Expression System for the β-Lytic Protease ofInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Takahiro HiokiBiological Science Research, Kao Corporation, 1334 Minato, Wakayama, Wakayama, 640-8580, Japan. hioki.takahiro@kao.com.ORCID http://orcid.org/0000-0002-4566-8368
Daichi YamashitaBiological Science Research, Kao Corporation, Haga , Tochigi, 2606 Akabane, Ichikai321-3497, Japan.
Masatoshi TohataSafety Science Research, Kao Corporation, 2606 Akabane, Ichikai, Haga, Tochigi, 321-3497, Japan.
Keiji EndoBiological Science Research, Kao Corporation, Haga , Tochigi, 2606 Akabane, Ichikai321-3497, Japan.
Akihito KawaharaBiological Science Research, Kao Corporation, 1334 Minato, Wakayama, Wakayama, 640-8580, Japan.
Mitsuyoshi OkudaBiological Science Research, Kao Corporation, Haga , Tochigi, 2606 Akabane, Ichikai321-3497, Japan.
Kao Corporation (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMost of the proteases classified into the M23 family in the MEROPS database exhibit staphylolytic activity and have potential as antibacterial agents. The M23 family is further classified into two subfamilies, M23A and M23B. Proteases of the M23A subfamily are thought to lack the capacity for self-maturation by auto-processing of a propeptide, which has been a challenge in heterologous production and application research. In this study, we investigated the heterologous expression, in Bacillus subtilis, of the Lysobacter enzymogenes beta-lytic protease (BLP), a member of the M23A subfamily.

resultsWe found that B. subtilis can produce BLP in its active form. Two points were shown to be important for the production of BLP in B. subtilis. The first was that the extracellular proteases produced by the B. subtilis host are essential for BLP maturation. When the host strain was deficient in nine extracellular proteases, pro-BLP accumulated in the supernatant. This observation suggested that BLP lacks the capacity for self-maturation and that some protease from B. subtilis contributes to the cleavage of the propeptide of BLP. The second point was that the thiol-disulfide oxidoreductases BdbDC of the B. subtilis host are required for efficient secretory production of BLP. We infer that intramolecular disulfide bonds play an important role in the formation of the correct BLP conformation during secretion. We also achieved efficient protein engineering of BLP by utilizing the secretory expression system in B. subtilis. Saturation mutagenesis of Gln116 resulted in a Q116H mutant with enhanced staphylolytic activity. The minimum bactericidal concentration (MBC) of the wild-type BLP and the Q116H mutant against Staphylococcus aureus NCTC8325 was 0.75 μg/mL and 0.375 μg/mL, respectively, and the MBC against Staphylococcus aureus ATCC43300 was 6 μg/mL and 3 μg/mL, respectively.

conclusionsIn this study, we succeeded in the secretory production of BLP in B. subtilis. To our knowledge, this work is the first report of the successful heterologous production of BLP in its active form, which opens up the possibility of industrial use of BLP. In addition, this study proposes a new strategy of using the extracellular proteases of B. subtilis for the maturation of heterologous proteins.

Indexed as

Bacillus subtilisBacterial ProteinsLysobacterMetalloendopeptidasesModels, MolecularMutationProtein ConformationProtein Disulfide Reductase (Glutathione)Protein EngineeringStaphylococcus aureusBacterial ProteinsMetalloendopeptidasesProtein Disulfide Reductase (Glutathione)staphylolytic proteaseBacillus subtilisBeta-lytic proteaseBLPHeterologous expressionM23 protease familyMRSAProtein engineeringStaphylococcus aureus

Identifiers

PMID34963446
PMCPMC8715609
OpenAlexW4200437887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.